KOOLD Investor Deck · 2026

The Pulse of Cold Chain.

Always monitoring. Always steady.

KOOLD · Pharma Cold Chain Intelligence Confidential · April 2026
KOOLD Philosophy
"

Nothing happened.
That's the job.

The invisible success of perfect cold chain management. Koold protects what matters — so your team never has to react.

KOOLD 02 / 09
KOOLD Get Started

Start with 5 sensors.
30 days. Full access.

No commitment. Complete visibility from day one.

Schedule a Consultation KOOLD.COM
Always monitoring. Always steady. 03 / 09
KOOLD Precision

We don't predict.
We precalculate.

Pharma-grade AI trained exclusively on cold chain data. Not generic IoT. Not a wrapper. A system built for the way pharma actually operates.

KOOLD · Pharma Cold Chain Intelligence 04 / 09
KOOLD By the Numbers
Words are cheap. Data is honest.
47
failures prevented
this month · one client
€40k
average cost per
cold chain incident
4.3s
alert response time
before teams wake up
0
GDP audit failures
across all clients
30+
pharma clients
DACH & BeNeLux
99.97%
platform uptime
full year 2025
KOOLD Internal Analytics · Q1 2026 05 / 09
KOOLD The Window
06 · Why Now

Three forces converging in 2026.

Regulation
DSCSA enforcement begins November 2026
Every pharma distributor must have end-to-end traceability. EMEA equivalents follow within 12 months. The deadline is non-negotiable.
SAP Shift
85% of large pharma migrating to S/4HANA by 2027
KOOLD integrates natively — no middleware required. The migration window is the sales window.
AI Maturity
AI predictive models now meet pharma-grade reliability
2025 model accuracy reaches GDP validation thresholds for the first time. The technology is ready. The market is not.
MarketsandMarkets · GS1 · FDA DSCSA 2026 06 / 09
KOOLD The Problem
07 · The Problem

Your cold chain has a pulse.
Most companies don't know it.

Most pharmaceutical supply chains run on assumption — not data, not certainty. A single temperature deviation can cost €40,000 and compromise patient safety. Regulations are tightening. The window is closing.

  • Cold chain failures cost the pharma industry €35B annually
  • 30% of temperature-sensitive shipments experience at least one excursion
  • DSCSA enforcement deadline: November 2026 — forces immediate action
WHO Cold Chain Report 2024 · IQVIA · GS1 07 / 09
KOOLD The Solution
08 · What We Built

AI-first. SAP-native.
Pharma-pure.

Sense
Real-time sensor telemetry from every point in the chain
IoT sensors stream temperature, humidity, and location data continuously. No manual checks. No gaps.
Predict
AI flags deviations before they happen
Machine learning models trained on pharma-specific cold chain patterns. 4.3 seconds average response.
Comply
SAP workflows and audit trails generated automatically
Native S/4HANA integration creates deviation records, alerts, and GDP documentation without human input.
  08 / 09
KOOLD Market
09 · The Market

€5.2B market. No dominant pharma-native player.

  • Global pharma cold chain market: €5.2B · 12% CAGR
  • DSCSA enforcement forces compliance spend in 2026
  • Competitors (SkyCell, Sensitech, Tive) are generic IoT — not pharma-native
  • No single player owns SAP-native + AI + pharma compliance
€5.2B
TAM · 2025
12%
CAGR through 2030
30+
Clients · Phase 1
Nov 26
DSCSA Deadline
Pilot Entry Point
5 sensors · 1 route · 30-day pilot.
No commitment. Converts at 78%.
MarketsandMarkets · IQVIA Cold Chain Report 2025 09 / 09